9th American Society of Gene Therapy Annual Meeting

Expert Opinion on Biological Therapy

Volumn 6, Issue 8, 2006, Pages 839-842

  Tan, P H ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Gene therapy; Immunology; Viral vectors

Indexed keywords

CONFERENCE PAPER; GENE THERAPY; IMMUNE RESPONSE; LITERATURE; MEDICAL INFORMATION; SOCIETY; UNITED STATES;

GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; TRANSGENES;

EID: 33746823883     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.6.8.839     Document Type: Conference Paper

References (20)

1. FISCHLE W, TSENG BS, DORMANN HL et al.: Regulation of HP1-chromatin binding by histone H3 methylation and phosphorylation. Nature (2005) 438(7071):1116-1122.
2. LI H, ILIN S, WANG W et al.: Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature (2006) (In Press).
3. MANNO CS, ARRUDA VR, PIERCE GF et al.: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. (2006) 12(3):342-347.
4. MANNO CS, ARRUDA VR, PIERCE GF et al.: CORRIGENDUM: Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. (2006) 12(5):592.
5. TAN PH, BEUTELSPACHER SC, XUE SA et al.: Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood (2005) 105(10):3824-3832.
6. HENSLEY SE, GILES-DAVIS W, MCCOY KC, WENINGER W, ERTL HC: Dendritic cell maturation, but not CD8+ T cell induction, is dependent on Type I IFN signaling during vaccination with adenovirus vectors. J. Immunol. (2005) 175(9):6032-6041.
7. RAYNER SA, LARKIN DF, GEORGE AJ: TNF receptor secretion after ex vivo adenoviral gene transfer to cornea and effect on in vivo graft survival. Invest. Ophthalmol. Vis. Sci. (2001) 42(7):1568-1573.
8. JUDGE AD, SOOD V, SHAW JR et al.: Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. (2005) 23(4):457-462.
9. ZIMMERMANN TS, LEE AC, AKINC A et al.: RNAi-mediated gene silencing in non-human primates. Nature (2006) 441(7089):111-114.
10. SAMAKOGLU S, LISOWSKI L, BUDAK-ALPDOGAN T et al.: A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nat. Biotechnol. (2006) 24(1):89-94.
11. MESEL-LEMOINE M, CHERAI M, LE GOUVELLO S et al.: Initial depletion of regulatory T cells: the missing solution to preserve the immune functions of T lymphocytes designed for cell therapy. Blood (2006) 107(1):381-388.
12. ZHANG H, CHUA KS, GUIMOND M et al.: Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat. Med. (2005) 11(11):1238-1243.
13. MCADAM AJ, GREENWALD RJ, LEVIN MA et al.: ICOS is critical for CD40-mediated antibody class switching. Nature (2001) 409(6816):102-105.
14. LATCHMAN Y, WOOD CR, CHERNOVA T et al.: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. (2001) 2(3):261-268.
15. KEIR ME, LIANG SC, GULERIA I et al.: Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. (2006) 203(4):883-895.
16. BARBER DL, WHERRY EJ, MASOPUST D et al.: Restoring function in exhausted CD8 T cells during chronic viral infection. Nature (2006) 439(7077):682-687.
17. TAN PH, XUE SA, MANUNTA M et al.: Effect of vectors on human endothelial cell signal transduction: implications for cardiovascular gene therapy. Arterioscler. Thromb. Vasc. Biol. (2006) 26(3):462-467.
18. TAN PH, YATES JB, XUE SA et al.: Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression. Blood (2005) 106(9):2936-2943.
19. TAN PH, SAGOO P, CHAN C et al.: Inhibition of NF-{kappa}B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J. Immunol. (2005) 174(12):7633-7644.
20. TAN PH, BEUTELSPACHER SC, WANG YH et al.: Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination. Mol. Ther. (2005) 11(5):790-800.